Manitimus

Manitimus Uses, Dosage, Side Effects, Food Interaction and all others data.

FK778, a novel compound with multiple mechanisms of action, is efficacious, well tolerated and safe in kidney transplant patients, potentially offering a breakthrough in immunosuppressive therapy.

Table Of contents

• Manitimus
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Manitimus
Generic	Manitimus
Manitimus Other Names	Manitimus
Type
Formula	C15H11F3N2O2
Weight	Average: 308.26 Monoisotopic: 308.077262091
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in immunosuppressive and transplant (rejection).

How Manitimus works

FK778 exerts its immunosuppressive activity at the molecular level via the suppression of de-novo pyrimidine biosynthesis, inhibiting the action of dihydroorotate dehydrogenase, an enzyme critical in the process, and consequently inhibiting cell proliferation.

Innovators Monograph

You find simplified version here Manitimus